IRVING, Texas, June 22 /PRNewswire-FirstCall/ -- RBC Life Sciences, Inc., (OTC Bulletin Board: RBCL) a provider of proprietary nutritional supplements and wound care/pain management products, announced today that the company's flagship antioxidant, Microhydrin, "significantly" reduced lactic acid buildup and improved hydration in horses during strenuous exercise.
"This and previous clinical trials prove that Microhydrin antioxidant has some very distinct and significant benefits to humans and animals participating in strenuous exercise or competition," said RBC Life Sciences' CEO and President John W. Price. "Studies have shown that lactic acid buildup can contribute to muscular acidosis and may inhibit optimal performance."
Conducted by the Equine Science Center at
The study found that the mares who received Microhydrin antioxidant in their feed had more than 13% lower blood lactate levels when they reached a fatigued state. The lactate levels were nearly 15% less up to 30-minutes after exercise. A similar study in human cyclists undergoing an endurance test showed a nearly 24% reduction in blood lactate concentration.
The mares fed Microhydrin antioxidant also lost less water weight during exercise, according to the study. Similarly, the human study showed that the cyclists maintained a better state of hydration after strenuous exercise.
Microhydrin's unique hydration characteristics stem from its unique composition of silica, potassium, magnesium and vitamin C. The antioxidant's colloidal silicate minerals display a variety of properties, including an increase in surface area--bonding absorbed water as well as minerals. Specific silicate interactions play a substantial role in nutrient bioavailability by enhancing solubility properties, improving ion and water transport and also providing free radical antioxidant protection.
About RBC Life SciencesRBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than 30 countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
|SOURCE RBC Life Sciences, Inc.|
Copyright©2009 PR Newswire.
All rights reserved